Autolus Therapeutics plc (NASDAQ:AUTL) Q1 2023 Earnings Call Transcript

Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics First Quarter 2023 Financial Results Conference Call and Operational Progress.

Related Keywords

Switzerland ,Mizuho ,Hokkaido ,Japan ,Chicago ,Illinois ,United States ,London ,City Of ,United Kingdom ,Stevenage ,Hertfordshire ,Spain ,Lugano ,Ticino ,American ,Mara Goldstein ,Alexandra Deschner ,John Johnson ,Gil Blum ,Chris Van ,Lucinda Crabtree ,Kelly Shi ,William Blair ,Lori Muffly ,Sara Ghorashian ,Yanan Zhu ,Claire Roden ,Matthew Gitlin ,Matthew Phipps ,Andreas Mackensen ,Drug Administration ,Needham Company ,Silicon Valley Bank ,American Society Of Hematology ,Stanford University ,Blackstone Life Sciences ,Us Cardinal Health ,European Hematology Association Congress ,Nasdaq ,International Conference For Malignant Lymphoma In Lugano ,Autolus Therapeutics Plc ,Cardinal Health ,University Of Erlangen Germany ,Autolus Therapeutics ,Call Transcript May ,Autolus Therapeutics First Quarter ,Results Conference Call ,Investor Relations ,Investor Relations Consultant ,Christian Itin ,Chief Executive Officer ,Chief Financial ,Private Securities Litigation Reform Act ,American Society ,Clinical Oncology Annual Meeting ,Claire Rode ,Tandem Meetings ,Erlangen Germany ,European Bone Marrow ,Transplant Meeting ,Great Ormond Street Hospital ,Molecular Therapy ,International Conference ,Malignant Lymphoma ,Annual Shareholder ,Autolus Board ,Capital Markets Day ,Professor Lori Muffly ,Autolu Chief Operating Officer ,Moderna Cabaletta ,Wells Fargo ,Asthika Goonewardene ,